Vimarsana
Biggest News Aggregation in the World

Alix Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alix Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alix Ventures Today - Breaking & Trending Today

Zafrens Raises $23M in Financing - Vimarsana News

Zafrens Raises $23M in Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

University of Glasgow spin-out Chemify raises £36m - Vimarsana News

University of Glasgow spin-out Chemify raises £36m

A Scottish firm bidding to speed up development of new medicines has secured £36 million in funding.

Scottish Company awarded £36 Million to advance Digitisation of Chemistry Labmate Online - Vimarsana News

Scottish Company awarded £36 Million to advance Digitisation of Chemistry Labmate Online

Molecular design, discovery and chemical manufacturing technology company Chemify has announced funding of £36 million including a Series A led by Triatomic Capital, joined by new investors including Hong-Kong based Horizon Ventures, US-based Rocketship Ventures, Possible Ventures, Alix Ventures, Scotland-based Eos and the UK Government Innovation Accelerator program. Click to read more...

Chemify Raises $43M in Series A Funding - Vimarsana News

Chemify Raises $43M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Chemify announces £36m of funding to digitise chemistry - Vimarsana News

Chemify announces £36m of funding to digitise chemistry

2.08.2023 - The funding will be used to accelerate the growth of the company and performance of its breakthrough technology platform. Chemify's technology platform enables optimal molecular designs for biological and industrial requirements, faster manufacturing at experimental scale of target molecules, libraries of complex scaffolds, and the assembly of otherwise unmakeable molecules and materia